数据链接：
官方服务：
资源简介：
Protocol for systematic review
应用场景：
创建时间：
2020-03-20
相关数据集
Table_1_Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.docx
Bladder cancer is characterized by its frequent recurrence and progression. Effective treatment strategies need to be based on an accurate risk stratification, in which muscle invasiveness and tumor g
frontiersin.figshare.com2023-06-01 更新100
North America Bladder Cancer Diagnostics Market Market
North America Bladder Cancer Diagnostics Market comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to fo
IMR REPORTS50
Cell-free lncRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer
To identify lncRNAs dysregulated in BC, we assessed the lncRNA expression profile in pooled urine samples of 10 BC patients and 10 controls by microarray. A total of 3093 lncRNAs determined differenti
NIAID Data Ecosystem30
Asia Pacific Bladder Cancer Diagnostics Market Market
The Asia Pacific Bladder Cancer Diagnostics Market market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into c
IMR REPORTS60
miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis
Aim: This study aimed to systematically evaluate the value of miRNA-143 in the early detection of bladder cancer (BCa). Methods: CNKI, WanFang, PubMed and Wiley Online Library databases
Taylor & Francis Group2024-08-05 更新40
